Ranran Shi
Impact in
-
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
-
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Chemical Synthesis and Analysis 3
- Metabolism, Diabetes, and Cancer 2
- Ion Transport and Channel Regulation 2
- Oncology 8
- Cancer Cells and Metastasis 4
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Shunzeng Lv (4 shared papers)Fei Li (1 shared paper)Shigang Zhao (1 shared paper)Hua Tian (1 shared paper)Yuting Liu (1 shared paper)Zhigeng Zou (1 shared paper)Kun Mu (3 shared papers)Bing Yan (3 shared papers)
- Journals
- Tumor Biology (2 papers)Journal of Molecular Neuroscience (2 papers)Scientific Reports (1 paper)Medicine (1 paper)Diabetes (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Ranran Shi
22 papers receiving 298 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 68
- Oncology 71
- Rheumatology 31
- Endocrinology, Diabetes and Metabolism 33
- Genetics 21
Countries citing papers authored by Ranran Shi
This map shows the geographic impact of Ranran Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranran Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranran Shi more than expected).
Fields of papers citing papers by Ranran Shi
This network shows the impact of papers produced by Ranran Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranran Shi. The network helps show where Ranran Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ranran Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: a meta-analysis. | 2015 | 64 |
| 2 | 2016 | 56 | |
| 3 | 2015 | 35 | |
| 4 | 2013 | 21 | |
| 5 | 2014 | 18 | |
| 6 | 2015 | 15 | |
| 7 | 2020 | 14 | |
| 8 | 2014 | 12 | |
| 9 | 2014 | 12 | |
| 10 | 2015 | 10 | |
| 11 | 2007 | 10 | |
| 12 | 2024 | 7 | |
| 13 | 2007 | 5 | |
| 14 | 2017 | 4 | |
| 15 | 2009 | 4 | |
| 16 | 2014 | 3 | |
| 17 | 2017 | 3 | |
| 18 | 2019 | 3 | |
| 19 | [Reversal of adriamycin resistance by digoxin in human breast cancer cell line MCF-7/adriamycin and its mechanism]. | 2015 | 2 |
| 20 | [Reversal of resistance to adriamycin in human breast cancer cell line MCF-7/ADM by silencing AEG-1 gene and its mechanism]. | 2014 | 2 |
About Ranran Shi
Ranran Shi is a scholar working on Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism, Cancer Research and Organic Chemistry, having authored 25 papers that have together received 302 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Chemical Synthesis and Analysis (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Neonatal Respiratory Health Research (2 papers) and Ion Transport and Channel Regulation (2 papers). The work is most often cited by research in Cancer Research (68 citations), Oncology (71 citations), Rheumatology (31 citations), Endocrinology, Diabetes and Metabolism (33 citations) and Genetics (21 citations). Ranran Shi has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Shunzeng Lv, Fei Li, Shigang Zhao, Hua Tian, Yuting Liu, Zhigeng Zou, Kun Mu, Bing Yan, Yan Wang and Xingchen Zhou. Their work appears in journals such as Tumor Biology, Journal of Molecular Neuroscience, Scientific Reports, Medicine and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.